Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Point72

Investor type Family Investment Office
Founders Steven A. Cohen

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$75M
Portfolio companies 13
Rounds per year 1.30
Lead investments 0
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Software
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Point72:
Typical Co-investors
Point72 is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Point72:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
8-Bit Capital California, San Francisco, United States
Annagram Ventures -
Bincot -
Commodore Capital New York, New York, United States
Cue Ball, LLC Boulder, Colorado, United States
Guodian Dianli China, Dalian, Zhejiang
HackerOne California, San Francisco, United States
HITO-Communications Japan, Toshima
Jiaxing Hongliu Investment -
KingMed Diagnostics China, Guangdong, Guangzhou
Kissei Pharmaceutical Japan, Matsumoto, Nagano Prefecture
Kuake Capital Chaoyang, China, Liaoning
LVP England, London, United Kingdom
MEST Express accelerator Accra, Ghana, Greater Accra
MLC50 England, London, United Kingdom
Ontario Pension Board Canada, Ontario, Toronto
PEAK6 Investments, L.P. Chicago, Illinois, United States
Sangel Biomedical Venture Capital -
Touchstone Innovations England, London, United Kingdom
Vetrargil Gullbringusysla, Iceland, Reykjavík

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kinly

Financial Services
FinTech
$15M13 Jun 2022 -

Atomic Industries

Industrial
Industrial Manufacturing
Machinery Manufacturing
Manufacturing
$3M05 Apr 2022 Los Angeles, California, United States

Korro Bio

Biotechnology
Pharmaceutical
$116M05 Jan 2022 Cambridge, Massachusetts, United States

Quell Therapeutics

Association
Biotechnology
Education
$156M29 Nov 2021 London, England, United Kingdom

LÜK Network

Internet
Marketplace
$4M01 Nov 2021 Los Angeles, California, United States

Vestwell

Finance
Financial Services
FinTech
Retirement
Software
$70M20 Jul 2021 New York, New York, United States

Turnstone Biologics

Biotechnology
Innovation Management
Therapeutics
$80M14 Jul 2021 San Francisco, California, United States

BioTheryX

Biotechnology
Health Care
Medical
Therapeutics
$92M20 May 2021 Chappaqua, New York, United States

Arch Oncology

Biotechnology
$105M27 Apr 2021 California, United States
News
Vestwell Raises $70M in Series C Funding

– Vestwell, a NYC-based API technology platform for workplace savings and investing programs, raised $70m in Series C financing.
– The round was led by Wells Fargo Strategic Capital and Fin Venture Capital co-led by Goldman Sachs, Morgan Stanley, Manulife, Point72, Nationwide Ventures, Allianz Life Ventures, Northwestern Mutual, FinTech Collective, Greenspring Associates, Primary Venture Partners, Teamworthy Ventures, F-Prime Capital, Industry Ventures, and Commerce Ventures.
– The company intends to use the funds to further expand the team, platform functionality, and servicing for its thousands of partners and clients.

Turnstone Biologics Raises $80 Million Series D Financing

– Turnstone Biologics Corp. announced the successful completion of an $80m Series D financing co-led by PFM Health Sciences and Point72.
– New investors include Eventide Asset Management, Surveyor Capital (a Citadel company), Ridgeback Capital Investments, Takeda Ventures, CaaS Capital, JM Family Enterprises, Inc., Northleaf Capital Partners, 404 Bio and an undisclosed investor.
– The round was joined by existing investors Versant Ventures, OrbiMed, F-Prime Capital, Sectoral Asset Management, Sixty Degree Capital, Brace Pharma Capital and Teralys Capital.
– Proceeds from the financing will be used to advance Turnstone’s pipeline of programs from its oncolytic virus and TIL therapy platforms.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Point72?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: